EBITDA: Income before interest, taxes, depreciation and amortization.
NovelStem International Corp. (NSTM) had EBITDA of $-0.04M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-0.09M |
|
-- |
|
-- |
|
$0.04M |
|
$-0.04M |
|
$-0.05M |
|
$-0.09M |
|
$-0.09M |
|
$-0.09M |
|
$-0.09M |
|
$-0.09M |
|
$-0.09M |
|
$-0.04M |
|
|
EBITDA |
$-0.04M |
46.88M |
|
47.80M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.02M |
|
-- |
|
-- |
|
$0.02M |
|
$2.16M |
|
-- |
|
-- |
|
$2.16M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
46.88M |
|
| Cash Flow Statement Financials | |
$-0.17M |
|
-- |
|
$0.16M |
|
$0.01M |
|
$0.00M |
|
$-0.01M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
-0.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
4.17% |
|
4.17% |
|
-565.66% |
|
4.17% |
|
$-0.05 |
|
$-0.00 |
|
$-0.00 |
|